86
Participants
Start Date
January 31, 2016
Primary Completion Date
February 28, 2019
Study Completion Date
February 28, 2019
Patient Self-Monitoring vs Anticoagulation Clinic
"Patient Self-Monitoring (intervention): entails 3 education sessions of 90-120 minutes each (week 0, week 2, week 4): 2 provided on site in clinic and 1 in the patient's home, during which, self-testing competency and barriers and facilitators to self-monitoring will be evaluated. Subjects will follow with weekly (or sooner, if clinically indicated) in-home self-monitoring and follow-up weekly phone calls over 6 months by clinical pharmacists to guide warfarin dosing and reinforce key educational messages.~Anticoagulation Clinic (control): subjects will have their INR tested in clinic monthly (or more frequently if clinically indicated) via the Coaguchek® point-of-care device (which is the standard of care in the Anticoagulation Clinic) and receive dosing instructions and standardized education related to warfarin by a clinical pharmacist who provides care in the Anticoagulation Clinic."
University of Illinois at Chicago, Chicago
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Roche Pharma AG
INDUSTRY
University of Illinois at Chicago
OTHER